Zhengye Biotechnology Holding Limited Announces Full Exercise of Underwriters’ Over-Allotment Option
14 janv. 2025 12h00 HE
|
Zhengye Biotechnology Holding Limited
Jilin, China, Jan. 14, 2025 (GLOBE NEWSWIRE) -- Zhengye Biotechnology Holding Limited (Nasdaq: ZYBT) (the "Company" or "Zhengye"), a veterinary vaccine manufacturer that encompasses research,...
Zhengye Biotechnology Holding Limited Announces Closing of Initial Public Offering
08 janv. 2025 12h00 HE
|
Zhengye Biotechnology Holding Limited
Jilin, China, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Zhengye Biotechnology Holding Limited (Nasdaq: ZYBT) (the "Company" or "Zhengye"), a veterinary vaccine manufacturer that encompasses research,...
Zhengye Biotechnology Holding Limited Announces Pricing of Initial Public Offering
06 janv. 2025 17h50 HE
|
Zhengye Biotechnology Holding Limited
Jilin, China, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Zhengye Biotechnology Holding Limited (the "Company" or "Zhengye"), a veterinary vaccine manufacturer that encompasses research, development,...